← Eichor
Condition: Idiopathic Pulmonary Fibrosis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Idiopathic Pulmonary Fibrosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Mechanisms of Familial Pulmonary Fibrosis
Phase N/A · 1 location(s) · Vanderbilt University Medical Center · NCT03437486The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
Phase N/A · 1 location(s) · University of Virginia · NCT06323876An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Phase 2 · 54 location(s) · Avalyn Pharma Inc. · NCT06951217AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF
Phase 2 · 3 location(s) · Avalyn Pharma Inc. · NCT07194382Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
Phase N/A · 1 location(s) · University of Pittsburgh · NCT00258570H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
Phase 2 · 1 location(s) · National Institute of Environmental Health Sciences (NIEHS) · NCT06325696Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
EARLY_Phase 1 · 1 location(s) · University of Virginia · NCT06853145Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Phase 3 · 1 location(s) · Argyrios Tzouvelekis · NCT07299695Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
Phase 1 · 1 location(s) · University of Alabama at Birmingham · NCT04362644A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
Phase 2 · 1 location(s) · Chiesi Farmaceutici S.p.A. · NCT07516951A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
Phase 2 · 46 location(s) · Boehringer Ingelheim · NCT07036523The Genetics of Pulmonary Fibrosis
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT03478553P4O2 ILD Extension
Phase N/A · 1 location(s) · Amsterdam UMC, location VUmc · NCT06644144Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis
Phase 2 · 1 location(s) · Mannkind Corporation · NCT07679893Maralixibat in Patients With Cystic Fibrosis and Constipation
Phase 2/Phase 3 · 1 location(s) · Children's Hospital Los Angeles · NCT06413368ILD-SARDs Registry and Biorepository
Phase N/A · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT05007340A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic
Phase 3 · 1 location(s) · Beijing Tide Pharmaceutical Co., Ltd · NCT07464912Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
Phase 1/Phase 2 · 2 location(s) · Paul Szabolcs · NCT03500731Controls for Respiratory Diseases
Phase N/A · 1 location(s) · Seoul National University Hospital · NCT03120481Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
Phase N/A · 1 location(s) · University of Pittsburgh · NCT00373841Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis
Phase N/A · 1 location(s) · University of California, Los Angeles · NCT06162884Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial
NA · 1 location(s) · Hospital de Granollers · NCT07482917Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF)
Phase 1 · 4 location(s) · Wuhan Optics Valley Vcanbiopharma Co., Ltd. · NCT06230822A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Phase 2 · 190 location(s) · AstraZeneca · NCT07652658Natural History of Noncirrhotic Portal Hypertension
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT02417740HOXB7 and Linked Tissue and Blood Biomarkers in the Lungs of Patients With Pulmonary Fibrosis
Phase N/A · 1 location(s) · University of Modena and Reggio Emilia · NCT07373288A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Pr
Phase 3 · 373 location(s) · Boehringer Ingelheim · NCT06238622Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT06036719Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF
Phase 3 · 1 location(s) · Sunshine Lake Pharma Co., Ltd. · NCT07082842Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed Tomography
Phase N/A · 5 location(s) · Azienda Unita Sanitaria Locale di Piacenza · NCT07174102
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.